Heparanase (HPSE) is the only mammalian endo-beta-glucuronidase known to catalyse the degradation of heparan sulfate. Dysfunction of HPSE activity has been linked to several disease states, resulting in HPSE becoming the target of numerous therapeutic programs, yet no drug has passed clinical trials to date. Pentosan polysulfate sodium (PPS) is a heterogeneous FDA-approved drug for the treatment of interstitial cystitis and a known HPSE inhibitor. However, due to its heterogeneity, characterisation of its mechanism of HPSE inhibition is challenging. Here we show that inhibition of HPSE by PPS is complex, involving multiple overlapping binding events, each influenced by factors such as oligosaccharide length and inhibitor-induced changes in protein secondary structure. The present work advances our molecular understanding of the inhibition of HPSE, which will aid the development of therapeutics for the treatment of a broad range of pathologies associated with enzyme dysfunction including cancer, inflammatory disease and viral infections.
Heparanase (HPSE) is the only mammalian endo-β-glucuronidase
known to catalyze the degradation of heparan sulfate. Dysfunction
of HPSE activity has been linked to several disease states, resulting
in HPSE becoming the target of numerous therapeutic programs, yet
no drug has passed clinical trials to date. Pentosan polysulfate sodium
(PPS) is a heterogeneous, FDA-approved drug for the treatment of interstitial
cystitis and a known HPSE inhibitor. However, due to its heterogeneity,
characterization of its mechanism of HPSE inhibition is challenging.
Here, we show that inhibition of HPSE by PPS is complex, involving
multiple overlapping binding events, each influenced by factors such
as oligosaccharide length and inhibitor-induced changes in the protein
secondary structure. The present work advances our molecular understanding
of the inhibition of HPSE and will aid in the development of therapeutics
for the treatment of a broad range of pathologies associated with
enzyme dysfunction, including cancer, inflammatory disease, and viral
infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.